CohBar Competitors and Similar CompaniesClear all
Novartis's competitors and similar companies include Pfizer, Moderna and Fortrea.
 Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. |  Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). | |
Founding Date | Founding Date 1996 | Founding Date 1849 | Founding Date 2010 | Founding Date 2023 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more | |
Employees | Employees 75,883 | Employees 81,0008% decrease | Employees 5,8004% increase | Employees 19,000 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 163.9 b | Valuation ($) 21.2 b | Valuation ($) 1.6 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $1.9b (FY, 2025) | Revenue (est.) $2.7b (FY, 2025) |
Cost of goods | Cost of goods $8.4b (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods $868m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $49.8b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit $1.1b (FY, 2025) | Gross profit N/A |
Net income | Net income $14b (FY, 2025) | Net income $7.8b (FY, 2025) | Net income ($2.8b) (FY, 2025) | Net income ($986.2m) (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries N/A | Countries 200 (FY, 2024) | Countries N/A | Countries 90 (Jul, 2023) |
Phase III Trials Products | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A | Phase III Trials Products N/A |
Registration Phase Products | Registration Phase Products 8 (FY, 2022) | Registration Phase Products 5 (FY, 2024) | Registration Phase Products N/A | Registration Phase Products N/A |
Funding | ||||
Total funding raised | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised $ 1.8b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Pfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyModerna
HQ
Cambridge, US
Employees
5,800↑ 4% increase
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
View companyFortrea
HQ
Durham, US
Employees
19,000
Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).
View company